Sichuan Taienkang Pharmaceutical Co., Ltd.

"Unlock Next-Gen Pharma Solutions with Sichuan Taienkang Pharmaceutical Co., Ltd! We’re proud to introduce our new portfolio of APIs & intermediates, engineered for higher purity (≥99.0%), regulatory compliance (GMP), and scalable production. Mian Products: #Avapritinib CAS: 888721-83-3 CAS: 1703794-33-5 CAS: 1704492-14-7 CAS: 1703794-73-3 #Belzutifan CAS: 1672665-29-0 CAS: 1672665-55-2 CAS: 1672668-41-5 #Lazertinib CAS: 1903009-55-1 CAS: 2438331-81-6 CAS: 2270944-70-0 CAS: 1903010-39-8 #Nirogacestat CAS: 1213536-98-1 CAS: 2097878-69-6 CAS: 865774-26-1 #Obicetrapib CAS: 952582-02-4 CAS: 769132-28-7 CAS: 952582-00-2 #Olutasidenib CAS: 20028-53-9 CAS: 327056-62-2 CAS: 1887009-48-4 CAS: 1887015-55-5 #Osilodrostat CAS: 127607-62-9 CAS: 928136-82-7 CAS: 928134-37-6 #Pirtobrutinib CAS: 298689-75-5 CAS: 1188083-45-5 CAS: 2089246-64-8 CAS: 2764851-03-6 #Tovorafenib CAS: 1095824-76-2 CAS: 1095824-77-3 CAS: 914916-98-6 CAS: 1956437-47-0 💡 Your Challenges, Our Expertise – Let’s discuss how these innovations can streamline your supply chain. 📩 Contact: sales@taienkangpharma.com 🌐 Website: www.taienkangpharma.com #taienkang

Dear Valued Partner, We are excited to invite you to visit Sichuan Taienkang Pharmaceuticals (Booth: E6D53) at CPHI Shanghai 2025 (June 24-26, Shanghai New International Expo Centre), Asia’s largest pharmaceutical sourcing platform. Highlights: 🫠 APIs and intermediates supplier 🫠 GMP-compliant manufacturer 🫠 Strong R&D abilities 🫠 DMF/CMC documents support "Your success drives our innovation" – Let’s discuss how we can support your 2025-26 projects. 📧 Email: sales@taienkangpharma.com Looking forward to connecting! #CPHICHINA #CPHISHANGHAI #CPHI #TAIENKANG

Our dear customers, Sichuan Taienkang has an excellent R&D team and can fastly respond to the market demand. Here we have a few dozens of new products developed with superior quality. Please contact us at below address if you are interested. E-mail: sales@taienkangpharma.com Web.: www.taienkangpharma.com Product Name&CAS No: Capivasertib， 1143532-39-1 (S)-3-Amino-3-(4-chlorophenyl)propan-1-ol， 886061-26-3； 4-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl) 4-piperidinecarboxylic acid， 956460-96-1； (S)-3-Amino-3-(4-chloro-phenyl)-propionic acid， 131690-60-3； (S)-Methyl 3-amino-3-(4-chlorophenyl)propanoate (hydrochloride)， 1217775-76-2； Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate， 115655-44-2； Ethyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate， 956460-98-3； 1-Tert-butyl 4-methyl 4-(tert-butoxycarbonylamino)piperidine-1,4-dicarboxylate， 1143534-94-4； (S)-3-((tert-butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid， 479064-90-9；   (S)-3-amino-3-(4-chlorophenyl)propanoic acid hydrochloride， 930769-55-4； 2-((S)-4-(7-(8-Chloronaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile， 2206737-06-4； 2890783-84-1； Nirogacestat， 1962925-29-6； (S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-aMine， 1213536-98-1； Pentanoic acid, 2-hydroxy-, 1,1-dimethylethyl ester, (2R)-， 2097878-69-6； 1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-amine， 865774-26-1； Obicetrapib， 866399-87-3； (2R,4S)-2-Ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-amine methanesulfonic acid， 952582-02-4； 1(2H)-Quinolinecarboxylic acid, 2-ethyl-3,4-dihydro-4-oxo-6-(trifluoromethyl)-, ethyl ester, (2R)-， 769132-28-7； 4(1H)-Quinolinone, 2-ethyl-2,3-dihydro-6-(trifluoromethyl)-, (2R)-， 952582-00-2； 3026251-31-7； 3026251-29-3； Olutasidenib， 1887014-12-1； 2-Amino-5-chlorobenzaldehyde， 20028-53-9； 2-Cyano-5-fluoropyridine， 327056-62-2； (S)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one， 1887009-48-4； 2-Pyridinecarbonitrile, 5-fluoro-1,6-dihydro-1-methyl-6-oxo-， 1887015-55-5； 2,6-Dichloroquinoline-3-carbaldehyde， 73568-41-9； 3-(allyloxymethyl)-4-(2-chloroethoxy)benzenamine Oxalate， 1312603-46-5； 3-(2-Chloro-pyrimidin-4-yl)-phenyl]-methanol， 859517-90-1； 14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-(2-chloroethoxy)-, (16E)-， 1312603-75-0； AMinoMethylboronic acid pinacol ester hydrochloride， 298689-75-5； 2-((4-bromophenyl)(methoxy)methylene)malononitrile， 1188083-45-5； Borate(1-), trifluoro[[(5-fluoro-2-methoxybenzoyl)amino]methyl]-, potassium (1:1)， 2089246-64-8； (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hydrochloride， 2764851-03-6； Semaglutide side chain， 1169630-40-3； Xanomeline， 131986-45-3； 2-Amino-2-(pyridin-3-yl)acetonitrile， 131988-63-1； 3-Chloro-4-(Pyridin-3-YL)-1,2,5-Thiadiazole， 131986-28-2； #intermediates #taienkang #T&K

Anhui Taienkang Pharmaceutical Co., Ltd. is one of Taienkang's subsidiary company. Anhui Taienkang specialized in producing FDFs and Biosimilar products (APIs). You are warmly welcomed to inquiry from us if you have demand for below products. #Semaglutide #Romiplostim #Ranibizumab #Insulin icodec

Taienkang has three R&D bases, which are respectively Shandong Hubble Kisen Biological Technology Co., Ltd., Bochuangyuan (BCY) Pharm Co., Ltd., and Sichuan Checo Pharmaceutical Technology Co., Ltd. Meanwhile, the company also cooperates closely with experts from well-known university or scientific research institutions in China, including Sichuan University and Chengdu Institute of Biology of the Chinese Academy of Sciences. The R&D team has more than 200 personnel, is composed of researchers with Ph.D. and masters academic background, as well as rich experience, such as extensive experience in the industry. There are multiple innovative and scarce talents in the team with strong capability and expertise in various reactions. The R&D center is equipped with the state-of-the-art equipment and instruments, enabling us to achieve product process development, analytical method development, quality studies, etc. The production capability ranges from grams to kilograms level in the laboratory. #Taienkang R&D #ShandongHubbleKisen #Sichuantaienkang

Sichuan Taienkang Pharmaceutical Co., Ltd. is a cGMP compliance manufacturer in China. We have below superior products would like to recommend. Please contact us if you are interested. #Acalabrutinib #939412-86-9 #1420478-87-0 #1420478-88-1 #850568-25-1 #1383385-64-5 #Avibactam #1416134-48-9 #1416134-49-0 #1192651-80-1 #1192651-49-2 #Belzutifan #1672665-29-0 #1672665-69-8 #1672665-55-2 #2738675-96-0 #Berotralstat #2602377-11-5 #640287-99-6 #2602377-06-8 #Deucravacitinib #1609394-10-6 #1352925-63-3 #679406-03-2 #Eluxadoline #1391712-57-4 #623950-02-7 #78515-16-9 #864825-23-0 #Encorafenib #1269440-69-8 #1269440-58-5 #1229025-32-4 #Elacestrant #34841-47-9 #722536-73-4 #32263-70-0 #722520-36-7 #722520-42-5 #2477812-39-6 #2477812-38-5 #722520-36-7 #Lumateperone tosylate #29976-53-2 #59564-59-9 #313544-31-9 #313369-25-4 #313368-85-3 #1059630-13-5 #Neratinib #848133-76-6 #524955-09-7 #Ozanimod #60899-34-5 #1306763-57-4 #Siponimod #957205-23-1 #800381-60-6 #1378888-43-7 #1230487-01-0 #Trilaciclib Dihydrochloride #5062-67-9 #1352999-04-2 #1547757-91-4 #1374635-87-6 #571189-49-6 #Tauroursodeoxycholic acid #Zavegepant #1414976-15-0 #868707-31-7 #855778-84-6 #349535-15-5 #1414976-14-9 E-mail 1: may.yang@taienkangpharma.com E-mail 2: sales@taienkangpharma.com Web: www.taienkangpharma.com

Congrats! Our manufacturing site has been qualified by a valuable customer. The audit was conducted based on GMP standards. Our facilities and quality management system are completely comply with cGMP standards. #Taienkang